Merck beats earnings expectations, raises sales outlook on strong demand for top drugs like Keytruda - CNBC
- Merck beats earnings expectations, raises sales outlook on strong demand for top drugs like Keytruda CNBC
- Merck & Co. (MRK US) Beats Profit Projections as Keytruda Sales Rise Bloomberg
- Merck Stock: Pharma Giant Posts Strong Results, But Outlook Falls Short Investor's Business Daily
- Merck Announces Second-Quarter 2024 Financial Results Yahoo Finance
- Merck beats profit and sales expectations amid Keytruda strength, but provides mixed full-year outlook MarketWatch